Featured
Posted in Uncategorized

First blog post

This is your very first post. Click the Edit link to modify or delete it, or start a new post. If you like, use this post to tell readers why you started this blog and what you plan to do with it.

post

Advertisements
Posted in Business, Healthcare, Medical

Lancet Market to 2022-Industry Analysis, Applications, Opportunities and Trends

Market Research Future adds new report of “Global Lancet Market Research Report- Forecast To 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the Key Players in This Market Are: F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Greiner Bio One International GmbH, Improve Medical Technology Co. Ltd, Terumo Medical Corporation, Bayer Cropscience Limited, HTL-STREFA S.A, Sarstedt AG & Co and Others

Key Findings:

  • The Global Lancets Market and is expected to reach USD 2,882.6 million by 2022
  • Regionally, North America holds the largest market share of global Lancets Market and is expected to grow at a CAGR of 11.2% during the forecast period from 2016-2022
  • On the basis of type, safety lancets accounts the largest market share in 2015 and is expected to reach USD 2,061.8 million by 2022.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2078

Market Segments:

Global Lancet market has been segmented on the basis of types which comprises of personal, safety and others. On the basis of end users which consists of hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics and others.

Market Highlight:

A blood lancet, or simply a lancet, is small therapeutic equipment utilized for blood testing utilized for various blood sampling applications. A blood lancet is a surgical tool with a two-fold edged or sharp edge needle. Lancets are utilized to make vein punctures, for example, a finger stick, to obtain small blood samples and are generally disposable.

Safety lancets are single-use gadgets/devices for narrow blood testing used by professionals in healthcare services. They are a necessary part to the sharps-injury aversion programs in hospitals, clinics, research centers, physicians’ offices and wherever both patients and experts need to feel safe. Needle-stick wounds and diseases can be avoided by utilizing Safety lancets.

Globally lancets are being utilized by patients who are affected by endocrine related complications, cardiovascular issues and many other issues. Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients.

The global market of lancets is growing rapidly because of the rising prevalence of diabetes and growing number of blood borne diseases across the globe. The global market of lancets is expected to reach USD 2,882.6 million in 2022 and is expected to grow with a CAGR of approximately 11.3% during the forecast period.

Study Objectives of Lancet Market:

To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Lancet market. To provide insights about factors affecting the market growth. To analyze the Lancet market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. To provide country level analysis of the market with respect to the current market size and future prospective. To provide country level analysis of the market for segments by type, by end users and its sub-segments.

Browse Report Details @ https://www.marketresearchfuture.com/reports/lancet-market

Regional Analysis of Lancet Market:

Globally North America is the largest market for Lancet. The North American market for Lancet is expected to grow at a CAGR of 11.2% during the forecasted period. This is due to increasing prevalence of diabetic patients. Europe is the second-largest market for Lancet with the market value of USD 592.8 million in 2015. Whereas Asia pacific is expected to be a growing market for Lancet market and expected to grow at a rapid rate.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Genetic Testing Industry Survey, Trends, Outlook, Overview and 2023 Forecast

Market Research Future adds new report of “Genetic Testing Market- Global Forecast To 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are:

  • Abbott Laboratories (US)
  • Bio-Rad Laboratories Inc. (US)
  • Illumina Inc. (US)
  • Myriad Genetics (US)
  • PerkinElmer Inc. (US)
  • QIAGEN N.V. (Germany)
  • Quest Diagnostics (US)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2009

Market Segments: 

Global genetic testing market has been segmented

  • On the basis of Type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016.
  • On the basis of Method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016.
  • On the basis of Type of Test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016.
  • On the basis of Indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.

Market Highlight:

Genetic testing involves the use of laboratory methods to study the genes inherited from mother or father. These tests may be used to identify increased risks of health problems, to diagnose the mutations in the genes, to choose treatments, or to assess responses to treatment.

The Global Genetic testing market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.

Intended Audience

  • Genetic testing products manufacturers and suppliers
  • Genetic testing services providers
  • Hospitals and clinics
  • Medical Research laboratories
  • Research and Development (R&D) Companies
  • Government authorities
  • Market Research and Consulting Service Providers
  • Potential Investors

Browse Report Details @ https://www.marketresearchfuture.com/reports/genetic-testing-market

Regional Analysis of Global Genetic Testing Market:  

Considering the global scenario of the market, due to continuous innovation, high awareness about the genetic testing and rapid adoption of new technology, Americas is largest market and was holding 46.3% market share of global Genetic testing in 2016. US is holding largest market share in North America region. European genetic testing market is expected to reach USD 2,553.10 million by 2023. On the other hand, due to increasing aging population and advances in the medical fields, the Asia-Pacific (APAC) is fastest growing market for Genetic testing and expected to grow at a CAGR of 10.1% during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness and lack of required infrastructure.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Medical Tourism Market Size, Share, Manufacturers, Countries and Forecasts to 2023

Market Research Future adds new report of “Medical Tourism Market Research Report- Global forecast till 2023” it contains Company information, geographical data and Table of Content

Medical Tourism is not new to the world; from ages people have been traveling overseas for medical treatments. Yet, over the last few years the world is resonating with the term called Medical Tourism or medical travel. The landscape for Medical Tourism has changed significantly owing to a various reasons. The Medical Tourism market is booming and expected to gain further prominence over the forecast period attributed to the economic growth across the globe.  Economic growth is also responsible for the ever changing preferences of destinations people travel to.

Asklepios Kliniken Verwaltungsgesellschaft mbH (Germany), Fortis Healthcare (India), Gleneagles Global Hospitals Group. (Singapore), Prince Court Medical Centre (Malaysia), Samitivej PCL (Thailand), Christus Muguerza (Mexico), and Anadolu Medical Center (Turkey) are some of the prominent players competing in the Global Medical Tourism Market and are profiled in MRFR Analysis.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1975

Medical Tourism Market – Overview

According to a recent study report published by the Market Research Future, The global market of Medical Tourism is projected to accrue at a rapid pace during the forecast period (2017 – 2023).  The Market is forecasted to account for an upsurge accretions of USD 226,762.7 Million by 2023with a whooping double digit CAGR of 21.4% during 2017 and 2023.

The staggering accruals of Medical Tourism Market are attributed to the advanced and cost effective technologies. The increasing globalization, increasing global capital funding and advancement in medical technology has led to the betterment of international healthcare services. Medical Tourism Market is majorly led by the Medical excellence along with international accreditation. Increasing accredited facilities is a prime factor propelling the market growth of Medical Tourism. High treatment costs and lengthy waiting times for medical procedures, being the two major factors in driving medical tourism, are also supported by easier and cheaper international travel. While the U.K.’s population prefers to travel abroad for bypassing long waits, patients from the U.S. travel outside for availing of treatments at cheaper costs.

Worldwide Governments are keen and rendering the maximum support to entitle their country as a successful destination concerning healthcare system under the 2020 Vision. They ensure that there are numerous Specialty hospitals and clinics that measure up to international standards. Further, they ensure that there are renowned medical schools to ensure that the myriad of doctors and specialists graduate from there every year. Along with carrying these activities Governments also ensure that while costs are kept relatively low, the standard remains above average and competitive with the global markets. This factor, especially makes medical and health tourism so popular. Holistic approach in providing services, quality of treatments, and highly specialized and educated staff are biggest competitive advantage a country can have. From the very first point of patient ´s contact with the call centres or reception staff to the aftercare and follow up with the patient, these hospitals provide them with a 5-star treatment in every point of view. They promise world´s best medical care and quality service and work really hard to keep it up.

One can never emphasize enough on the role of the private-public sector and the key public and government institutions on board of all the major initiatives and projects that would ultimately lead to a faster development of medical tourism. The policies that involve strategic and business-friendly visa regimes, taxation, investment levels, supporting infrastructure are all conducive to a healthier Medical tourism and network management growth. Tourist Boards introduce different websites for health tourism that connects private and public sector initiatives with potential medical travellers. Public sector has a great role in positioning a nation as one of leading destinations for medical travellers. Ministry of Tourism, Ministry of Health, Chamber of Commerce, Tourist Board, and medical clusters are all working on this important vision of branding and positioning of a nation.

Some hospitals in the market are developing a Health and Wellness Destination Guide. They consider such tool as necessary or preconditions for entering international markets after positioning the country as top notch destination for Medical Tourism.

Medical Tourism Market – Segments

The Medical Tourism Market is segmented in to 2 key dynamics for the convenience of the report and enhanced understanding;

  • Segmentation By Treatment: Comprises Cosmetic Surgery, Dentistry, Cardiology/ Cardiovascular Surgery, Orthopaedic Surgery, Spine Treatments, Bariatric Surgery, Fertility/Reproductive System, Dental Treatments, Neurology/Neurosurgery Treatments, Fertility/IVF Treatments, Organ and Tissue Transplantation, Eye Surgery and Others.
  • Segmentation By Regions: Comprises Geographical regions – North America, Europe, APAC and Rest of the World.

Segment Cosmetic Treatments accounts for the largest market share which is 20%; followed by Dental and Orthopaedic/ Spine Treatments Segments which is 15% of market share. Cardiovascular/ Cardiology Treatments account for 13% of the market share. Neurology/ Neurosurgery Treatments, Fertility/ IVF Treatments and other hold for 10%, 8% and 6% of market share respectively.

Browse Report Details @ https://www.marketresearchfuture.com/reports/medical-tourism-market

Medical Tourism Market – Regional Analysis

The Asia Pacific region accounted for the largest share of the global medical tourism market, which had a lion share of 43.7% in 2016. This growth was attributed to heavy investment in infrastructure development, rising economy, technology up gradation, low cost and quality medical services, and government initiative to promote medical tourism in this region. Medical Tourism Market in India is booming attributed to the latest, low-cost technologies. The industry has evolved into a fully-fledged luxury market. Latest medical technologies in Indian hospitals at a lower cost is majorly contributing towards the country emerging as the premier Medical Tourism hub of the world. Treatments provided in India from accredited facilities are at par with any developed country in the world but at a lower cost, thus making giving Medical Tourism a competitive advantage over others. The digitisation in the health industry will also make the flow of foreign patients easier in the upcoming time.

America holds the second position in the medical tourism, which is followed by Europe. Central and South American countries such as Mexico, Costa Rica, and Brazil are some of the most popular destinations for Americans and Canadians. The American medical tourism market is expected to grow till USD 102,496.8 million at a CAGR of 22% by end of the 2023.

Europe is the growing market for the medical tourism. Since people from Western Europe are traveling to America to seek cost-effective treatments, which has relaxed the growth of the market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Cystic Fibrosis Market Size, Share, Manufacturers, Countries and Forecasts to 2022

Market Research Future adds new report of “Cystic Fibrosis Market Research Report – Global Forecast To 2022” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are: Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, Genentech, Pharmaxis, Chiesi Farmaceutici, Forest Laboratories and others.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1825

Market Segments: 

Cystic fibrosis market has been segmented on the basis of diagnostic test which comprises of immunoreactive trypsinogen (IRT) test, sweat chloride test, sputum test, chest X-ray, CT scan and pulmonary function test. On the basis of treatments, market is segmented into medical therapy, surgical treatment and others. On the basis of drug type, market is segmented into small molecules and biologics.

Market Highlight:

Cystic fibrosis is a genetic condition that causes severe damage to the respiratory and digestive systems. The damage is often caused due to buildup of thick, sticky mucus in the organs. The most commonly affected organs by cystic fibrosis are lungs, pancreas, liver and intestines. Every year, approximately 1000 people are diagnosed with this serious condition in United States. Globally the market for cystic fibrosis is increasing rapidly. Globally the market for cystic fibrosis is expected to grow at the rate of about from 2016 to 2022.

Study objectives of Cystic Fibrosis Market:

To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the cystic fibrosis market. To provide insights about factors affecting the market growth. To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. To provide country level analysis of the market with respect to the current market size and future prospective. To provide country level analysis of the market for segments by diagnostic test, by treatment, by drug type and its sub-segments.

Browse Report Details @ https://www.marketresearchfuture.com/reports/cystic-fibrosis-market

Regional Analysis of Cystic Fibrosis Market:               

Globally North America is the largest market for cystic fibrosis. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for cystic fibrosis.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Drug Allergy Market Overview – Key Futuristic Trends and Opportunities 2023

Market Research Future adds new report of “Drug Allergy Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Drug allergy is one of the most common types of allergies. It is the hyper sensitivity of the immune system to drug or medication. Any types of drugs such as prescription, nonprescription or herbal can induce drug allergy. Some common symptoms of the drug allergies are hives, skin rash, itching of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can relieve and prevent severe reactions.

Competitive Analysis:

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4033

Market Segments:

The global drug allergy market is segmented on the basis of type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance, and others. On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test, and others. On the basis of treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others. On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Market Highlight:

Increasing awareness about various allergies, the introduction of the new treatment of products and rising demand from emerging markets drives the growth of the global market. New research to prevent drug allergies is another key driver for the market. The global drug allergy market is growing moderately and is expected to continue its growth over the forecast period.

The global drug allergy market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Browse Report Details @ https://www.marketresearchfuture.com/reports/drug-allergy-market-4033

Regional Analysis of the Global Drug Allergy Market    

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Whipple’s Disease Market expected to cross USD 255.3 million by 2023

Market Research Future adds new report of “Whipple’s Disease Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Henry Schein, Inc. (US), Pfizer Inc. (US)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4094

Market Segments:

The global Whipple’s disease market is segmented on the basis of diagnosis, which includes physical exam, biopsy, blood tests, polymerase chain reaction, endoscopy, and others. Biopsy plays important role in diagnosis of this disorder, these tests include needle biopsy, CT-guided biopsy, ultrasound-guided biopsy, aspiration biopsy (fine-needle aspiration), skin biopsy, surgical biopsy, and others. Blood tests sub-segmented into Complete blood count (CBC), Red Blood Cell Count (RBC), serum albumin test, total protein test, and others. On the basis of treatments, the market is segmented into medications, supplements, and others. Medications is sub-segmented into Intravenous (IV) ceftriaxone (Rocephin), Intravenous (IV) penicillin, sulfamethoxazole-trimethoprim, SMX-TMP, oxycycline (Vibramycin), hydroxychloroquine (Plaquenil), and others. Supplements include vitamin supplements, mineral supplements, and others. On the basis of end user, it is segmented into hospitals & clinics, academic institutes, medical research centers, and others.

Market Highlight:

Whipple’s disease (WD) is a rare, chronic, systemic infectious bacterial disease caused by Tropheryma whipplei that affects gastrointestinal system, especially,  the small intestine. The infection may spread to any part of the body but mostly it affects the central nervous system, joints, lungs, heart, and eyes. Some common symptoms of this disease are weight loss, diarrhea, abdominal cramping and pain, weakness, fatigue, anemia, inflamed joints, and some other less common symptoms. The prevalence is one in one million people. The prevalence of this diseases is more in men than women.

Ongoing research and clinical trial to find effective cure drive the growth of market. Advancement in medical technology and increasing awareness about this disease boost the market growth.

The global Whipple’s disease market is expected to grow at the CAGR of ~3.1% during the forecast period and is estimated to reach USD 255.3 million by 2023.

Regional Analysis of the Global Whipple’s Disease Market   

The Americas holds the largest share in the global Whipple’s disease market. North American region, especially, the US dominates the market in this region. It is a rare disease and found in around less than one in million people in US. Some other factors such as advanced medical facilities, ongoing research and clinical trials, and availability of skilled health professionals. Increasing awareness about this disease in Latin America drives market growth in this region.

The new cases of this disease is increasing in Europe. Availability of advanced diagnostic and therapeutic options, high awareness among the European population, and availability of skilled medical professional drive the European market. Availability of cost-effective of treatment in East European countries, for instance,  Poland than the other parts of the region add fuel to the growing demand. Owing to availability of cost-effective treatment, patients from Western European countries and Russia travel to East and Central European countries to treat this disease.

Browse Report Details @ https://www.marketresearchfuture.com/reports/whipple-s-disease-market-4094

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Whipple’s Disease Market by Diagnosis
  7. Global Whipple’s Disease Market by Treatment
  8. Global Whipple’s Disease Market by End User
  9. Global Whipple’s Disease Market by Region
  10. Competitive Landscape
  11. Company Profile
  12. Conclusion
  13. Appendix

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Eye Allergy Treatment Market to See Incredible Growth of 5.2% by 2024

Market Research Future adds new report of “Eye Allergy Treatment Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are: ALLERGAN (Republic of Ireland), Johnson & Johnson Vision Care, Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Regeneron Pharmaceuticals, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Santen Pharmaceutical Co., Ltd.(Japan), Valeant (Canada) Shire (Republic of Ireland), and others.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/3811

Market Segments:

Global Eye Allergy Treatment market has been segmented on the basis of type which comprise seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. Vernal keratoconjunctivitis includes palpebral, limbal, corneal, and others. On the basis of treatment, the market has been segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. Decongestants are further sub-segmented into with or without antihistamines. Allergy shots (immunotherapy) is sub-segmented into Subcutaneous Immunotherapy Treatment (SCIT) and Sublingual Immunotherapy Treatment (SLIT). On the basis of end user, it is segmented into eye hospitals & clinics, medical institutes, research centers, and others.

Market Highlight:

Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Some of the common eye allergy symptoms are redness, itching, and burning.

Increasing prevalence of various eye allergies are key driver for the market while some other factors like increasing awareness, technological advancements, new therapies, and increasing healthcare expenditure are also major driving forces of global eye allergy treatment market.

The global eye allergy treatment market is expected to grow at the CAGR of ~5.2% during the forecast period and estimated to reach US$ 6845.3million by 2023.

Study objectives of global Eye Allergy Treatment market:

To provide detailed analysis of the global eye allergy treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments. To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global eye allergy treatment market. To provide detailed analysis of the market segmented by type, treatment, end user, and its sub-segments. To provide a detailed analysis of global eye allergy treatment market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc. To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

Browse Report Details @ https://www.marketresearchfuture.com/reports/eye-allergy-treatment-market-3811

Regional analysis of global eye allergy treatment market:  

Considering the global scenario of the market, the Americas dominate global market due to various factors such as large amount of money invested in R&D, new approvals for various dugs and medicine etc. European market is second largest and is expected to grow significantly during the forecast period. Due to rapidly developing healthcare facilities, rising healthcare expenditure, increasing investment in technology advancement, Asia Pacific region is the fastest growing in global eye allergy market. Middle East & Africa market is also growing but is expected to grow slower than the global average.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Tissue Microarray Industry Survey, Trends, Outlook, Overview and 2023 Forecast

Market Research Future adds new report of “Tissue Microarray Market Research Report- Global forecast to 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

  • Abcam plc. (U.K)
  • Externautics (Italy)
  • Asterand Bioscience (U.S)
  • Auria Biopankki (Finland)
  • US Biomax Inc. (U.S)
  • Protein Biotechnologies Inc. (U.S)
  • OriGene Technologies Inc. (U.S)
  • Novus Biologicals LLC (U.S)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1213

Market Segmentation:

Global Tissue microarray market has been segmented

  • On the basis of Type of Tissue Microarray which includes cell line, frozen tissue array, paraffin embedded tissue array
  • On the basis of Application the market is segmented into immunohistochemistry, FISH, mRNA in situ hybridization, nucleic acid extraction
  • On the basis of End Users are hospitals, clinics, diagnostic centers, research laboratories

Market Highlight:

Tissue microarray enables thorough analysis of multiple tissues or cell samples. Large amount of data is generated automatically providing reliable results. Results for large number of samples can be obtained within seconds at the same time. Another advantage of tissue microarray is that only small amount of tissue sample is needed. It is used in global analysis of protein expression in normal human tissues, cancer and cell lines within Human Protein Atlas (HPA). These advantages favor the growth of tissue microarray market. Wide application of tissue microarray in pathology also drive this market. Increasing application of tissue microarray in drug discovery and oncology, automated analysis of results and influence of technology drive this market. Drawback of tissue microarray is that it may not be fruitful for heterogeneous cancers and the sample may not represent the entire tumor. Global market of tissue microarray is expected to reach USD 340 billion in 2023 from USD 220 billion in 2016 with a CAGR of approximately 13.7% during the forecast period 2017-2023.

Browse Report Details @ https://www.marketresearchfuture.com/reports/tissue-microarray-market

Study objectives:

Main objective of this research is to provide information about Tissue microarray market, type of tissue microarray, application and end-users.

  • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the tissue microarray market.
  • To provide insights about factors affecting the market growth.
  • To analyze the tissue microarray market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific and Middle East and Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective.
  • To provide country level analysis of the market for segments by type, by application, by end users and its sub-segments.

Intended Audience

  • Medical device manufacturers
  • Medical device suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Academic Medical Institutes and Universities

Enquire about this Report @ https://www.marketresearchfuture.com/enquiry/1213

Regional Analysis:

Globally, tissue microarray market consists of four regions Americas, Europe, Asia-Pacific and Middle East and Africa. America is the largest market. Increase in technology adoption, rising incidence of cancer and increasing healthcare expenditure drive this market in America. Europe is the second largest market. Asia Pacific shows steady growth in this market. The market shows slow growth in Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Posted in Business, Healthcare, Medical

Genetic Testing Market – Current Trends, Opportunities and Challenges

Market Research Future adds new report of “Genetic Testing Market- Global Forecast To 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Some of the key players in this market are:

  • Abbott Laboratories (US)
  • Bio-Rad Laboratories Inc. (US)
  • Illumina Inc. (US)
  • Myriad Genetics (US)
  • PerkinElmer Inc. (US)
  • QIAGEN N.V. (Germany)
  • Quest Diagnostics (US)

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2009

Market Segments: 

Global genetic testing market has been segmented

  • On the basis of Type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016.
  • On the basis of Method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016.
  • On the basis of Type of Test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016.
  • On the basis of Indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.

Market Highlight:

Genetic testing involves the use of laboratory methods to study the genes inherited from mother or father. These tests may be used to identify increased risks of health problems, to diagnose the mutations in the genes, to choose treatments, or to assess responses to treatment.

The Global Genetic testing market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.

Intended Audience

  • Genetic testing products manufacturers and suppliers
  • Genetic testing services providers
  • Hospitals and clinics
  • Medical Research laboratories
  • Research and Development (R&D) Companies
  • Government authorities
  • Market Research and Consulting Service Providers
  • Potential Investors

Browse Report Details @ https://www.marketresearchfuture.com/reports/genetic-testing-market

Regional Analysis of Global Genetic Testing Market:  

Considering the global scenario of the market, due to continuous innovation, high awareness about the genetic testing and rapid adoption of new technology, Americas is largest market and was holding 46.3% market share of global Genetic testing in 2016. US is holding largest market share in North America region. European genetic testing market is expected to reach USD 2,553.10 million by 2023. On the other hand, due to increasing aging population and advances in the medical fields, the Asia-Pacific (APAC) is fastest growing market for Genetic testing and expected to grow at a CAGR of 10.1% during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness and lack of required infrastructure.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com